Vanda Pharmaceuticals Inc’s Shares Reel: -4.51% Quarterly Revenue Decline Amid 243.35M Market Cap

The market performance of Vanda Pharmaceuticals Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $8.15 on 02/09/23, while the lowest value for the same duration was $3.30 on 11/10/23.

52-week price history of VNDA Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Vanda Pharmaceuticals Inc’s current trading price is -48.10% away from its 52-week high, while its distance from the 52-week low is 28.38%. The stock’s price range during the 52-week period has remained between $3.30 and $8.15. In the Healthcare sector, the company’s shares saw a trading volume of around 1.37 million for the day, which was evidently higher than the average daily volume of 0.97 million over the past three months.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Market Capitalization and Financial Performance: An In-Depth Look

Vanda Pharmaceuticals Inc (VNDA) has experienced a quarterly decline of -4.51% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 243.35M and boasts a workforce of 290 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 4.03, with a change in price of -0.40. Similarly, Vanda Pharmaceuticals Inc recorded 954,085 in trading volume during the last 100 days, posting a change of -8.51%.

Examining VNDA’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for VNDA stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.

VNDA Stock Stochastic Average

Vanda Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 74.02%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 88.43%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 49.23% and 27.74%, respectively.

VNDA Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price increase of 0.24%. However, over the past six months, we’ve seen a stronger performance of -29.85%. The price of VNDA fallen by 1.44% over the last 30 days. And in the last five days, it has surged by 13.40%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts